Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study

MLA

Rocío Nayeli Sánchez-Santillán, et al. “Endothelial Biomarkers (Von Willebrand Factor, BDCA3, Urokinase) as Predictors of Mortality in COVID-19 Patients: Cohort Study.” BMC Pulmonary Medicine, vol. 24, no. 1, July 2024, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12890-024-03136-0.

APA

Rocío Nayeli Sánchez-Santillán, Martha Patricia Sierra-Vargas, Dulce González-Islas, Octavio Gamaliel Aztatzi-Aguilar, Rogelio Pérez-Padilla, Arturo Orea-Tejeda, Yazmín Debray-García, Manolo Ortega-Romero, Candace Keirns-Davis, Alejandra Loaeza-Roman, & Alejandra Rios-Pereda. (2024). Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study. BMC Pulmonary Medicine, 24(1), 1–8. https://doi.org/10.1186/s12890-024-03136-0

Chicago

Rocío Nayeli Sánchez-Santillán, Martha Patricia Sierra-Vargas, Dulce González-Islas, Octavio Gamaliel Aztatzi-Aguilar, Rogelio Pérez-Padilla, Arturo Orea-Tejeda, Yazmín Debray-García, et al. 2024. “Endothelial Biomarkers (Von Willebrand Factor, BDCA3, Urokinase) as Predictors of Mortality in COVID-19 Patients: Cohort Study.” BMC Pulmonary Medicine 24 (1): 1–8. doi:10.1186/s12890-024-03136-0.